The Pennant Group (NASDAQ:PNTG - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 1.110-1.110 for the period, compared to the consensus estimate of 1.100. The company issued revenue guidance of $865.0 million-$865.0 million, compared to the consensus revenue estimate of $833.4 million.
The Pennant Group Stock Performance
PNTG stock traded up $0.23 during midday trading on Friday, hitting $28.40. 421,200 shares of the stock traded hands, compared to its average volume of 226,343. The firm has a market cap of $986.10 million, a P/E ratio of 41.77, a PEG ratio of 2.24 and a beta of 1.56. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The stock's fifty day simple moving average is $25.04 and its 200-day simple moving average is $27.32. The Pennant Group has a 1-year low of $21.18 and a 1-year high of $37.13.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the stock. Stephens reaffirmed an "overweight" rating and set a $38.00 price objective on shares of The Pennant Group in a report on Wednesday, April 2nd. Truist Financial decreased their price target on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating on the stock in a research note on Friday, March 7th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $34.80.
View Our Latest Report on PNTG
About The Pennant Group
(
Get Free Report)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
See Also
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
